Evaluation of 3 Intraocular Lenses Following Lens Extraction

February 12, 2014 updated by: Bausch & Lomb Incorporated

A Three Arm Prospective Clinical Evaluation of Three FDA Approved Intraocular Lenses Designed to Improve Distance, Intermediate and Near Vision Following Lens Extraction.

The objective of this study is to evaluate the efficacy and subject satisfaction with three different FDA approved lenses for adults over 40 years of age who desire a reduction in spectacle dependence.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

78

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Aliso Viejo, California, United States, 92656
        • Bausch & Lomb, Inc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Subjects must have a clinically documented diagnosis of age-related bilateral cataracts that are considered amenable to treatment with standard phacoemulsification cataract extraction.
  • Subjects must require a spherical lens power from 10.00 D to 33.00 D
  • Subjects must have the potential for corrected distance visual acuity (CDVA) of 20/32 or better in both eyes, as documented by a Potential Acuity Meter

Exclusion Criteria:

  • Subjects with conditions with increased risk of zonular rupture, such as pseudoexfoliation syndrome. Zonular rupture during cataract surgery may affect postoperative centration, tilt, and stability of the lens.
  • Subjects who have any active inflammation or edema (swelling) of the cornea, including but not limited to the following: keratitis, keratoconjunctivitis, and keratouveitis.
  • Subjects with visually significant diabetic retinopathy (proliferative or non-proliferative) which reduces potential acuity to 20/32 or worse.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Crystalens AO
Eligible subjects to undergo small incision cataract surgery and were implanted with the Crystalens AO bilaterally.
Crystalens AO surgically implanted bilaterally. Study observation up to 180 days.
ACTIVE_COMPARATOR: ReSTOR
Eligible subjects to undergo small incision cataract surgery and were implanted with the ReSTOR IOL bilaterally.
ReSTOR surgically implanted bilaterally. Study observation up to 180 days.
ACTIVE_COMPARATOR: Tecnis Multifocal IOL
Eligible subjects to undergo small incision cataract surgery and were implanted with the Tecnis Multifocal IOL bilaterally.
Tecnis surgically implanted bilaterally. Study observation up to 180 days.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mesopic Monocular Contrast Sensitivity Without Glare 1.5 and 3 Cycles/Degree
Time Frame: Postoperative visit 3 (2-3 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Postoperative visit 3 (2-3 months)
Mesopic Monocular Contrast Sensitivity Without Glare 6 Cycles/Degree
Time Frame: Postoperative visit 3 (2-3 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Postoperative visit 3 (2-3 months)
Mesopic Monocular Contrast Sensitivity Without Glare 12 Cycles/Degree
Time Frame: Postoperative visit 3 (2-3 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Postoperative visit 3 (2-3 months)
Mesopic Monocular Contrast Sensitivity Without Glare 18 Cycles/Degree
Time Frame: Postoperative visit 3 (2-3 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Postoperative visit 3 (2-3 months)
Mesopic Monocular Contrast Sensitivity Without Glare 1.5 Cycles/Degree
Time Frame: Postoperative visit 4 ( 4-6 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Postoperative visit 4 ( 4-6 months)
Mesopic Monocular Contrast Sensitivity Without Glare 3 Cycles/Degree
Time Frame: Postoperative visit 4 ( 4-6 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Postoperative visit 4 ( 4-6 months)
Mesopic Monocular Contrast Sensitivity Without Glare 6 Cycles/Degree
Time Frame: Postoperative visit 4 ( 4-6 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Postoperative visit 4 ( 4-6 months)
Mesopic Monocular Contrast Sensitivity Without Glare 12 Cycles/Degree
Time Frame: Postoperative visit 4 ( 4-6 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Postoperative visit 4 ( 4-6 months)
Mesopic Monocular Contrast Sensitivity Without Glare 18 Cycles/Degree
Time Frame: Postoperative visit 4 ( 4-6 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Postoperative visit 4 ( 4-6 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Binocular Mesopic Contrast Sensitivity Without Glare 1.5 & 3 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 3 (2-3 months)
Binocular Mesopic Contrast Sensitivity Without Glare 6 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 3 (2-3 months)
Binocular Mesopic Contrast Sensitivity Without Glare 12 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 3 (2-3 months)
Binocular Mesopic Contrast Sensitivity Without Glare 18 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 3 (2-3 months)
Binocular Mesopic Contrast Sensitivity Without Glare 1.5, 3, 6 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 4 (4-6 months)
Binocular Mesopic Contrast Sensitivity Without Glare 12 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 4 (4-6 months)
Binocular Mesopic Contrast Sensitivity Without Glare 18 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) without glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 4 (4-6 months)
Mesopic Monocular Contrast Sensitivity With Glare 1.5 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 3 (2-3 months)
Mesopic Monocular Contrast Sensitivity With Glare 3 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 3 (2-3 months)
Mesopic Monocular Contrast Sensitivity With Glare 6 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 3 (2-3 months)
Mesopic Monocular Contrast Sensitivity With Glare 12 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 3 (2-3 months)
Mesopic Monocular Contrast Sensitivity With Glare 18 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 3 (2-3 months)
Mesopic Monocular Contrast Sensitivity With Glare 1.5 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 4 (4-6 months)
Mesopic Monocular Contrast Sensitivity With Glare 3 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 4 (4-6 months)
Mesopic Monocular Contrast Sensitivity With Glare 6 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 4 (4-6 months)
Mesopic Monocular Contrast Sensitivity With Glare 12 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 4 (4-6 months)
Mesopic Monocular Contrast Sensitivity With Glare 18 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 4 (4-6 months)
Mesopic Binocular Contrast Sensitivity With Glare 1.5, 3 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 3 (2-3 months)
Mesopic Binocular Contrast Sensitivity With Glare 6 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 3 (2-3 months)
Mesopic Binocular Contrast Sensitivity With Glare 12 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 3 (2-3 months)
Mesopic Binocular Contrast Sensitivity With Glare 18 Cycles/Degree
Time Frame: Visit 3 (2-3 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 3 (2-3 months)
Mesopic Binocular Contrast Sensitivity With Glare 1.5, 3 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 4 (4-6 months)
Mesopic Binocular Contrast Sensitivity With Glare 6 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 4 (4-6 months)
Mesopic Binocular Contrast Sensitivity With Glare 12 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 4 (4-6 months)
Mesopic Binocular Contrast Sensitivity With Glare 18 Cycles/Degree
Time Frame: Visit 4 (4-6 months)
Logarithm of the mesopic (low light) contrast sensitivity (ability to detect detail with subtle gradations of grayness between test target and background) with glare at five spatial frequencies (number of light and dark bars per cycle). A higher mean indicates improved contrast sensitivity
Visit 4 (4-6 months)
Optical Scatter
Time Frame: Visit 3 (2-3 months)
Objective scatter index (OSI) was assessed using the Optical Quality Analysis System(OQAS) and summarized as a continuous variable. For this assessment, an OSI score of 1 or less represents good quality vision, 1-2 indicates some degradation but otherwise normal vision, 2-3 significant light scatter possibly requiring treatment, and scores over 4 severely compromised vision requiring intervention.
Visit 3 (2-3 months)
Optical Scatter
Time Frame: Visit 4 (4-6 months)
Objective scatter index (OSI) was assessed using the Optical Quality Analysis System(OQAS) and summarized as a continuous variable. For this assessment, an OSI score of 1 or less represents good quality vision, 1-2 indicates some degradation but otherwise normal vision, 2-3 significant light scatter possibly requiring treatment, and scores over 4 severely compromised vision requiring intervention.
Visit 4 (4-6 months)
Monocular Halo and Starburst
Time Frame: Visit 3 (2-3 months)
Halo and starburst (both monocular and binocular) were measured using a glarometer on integer scales of 1-5, where the smaller the number the better the outcome.
Visit 3 (2-3 months)
Monocular Halo and Starburst
Time Frame: Visit 4 (4-6 months)
Halo and starburst (both monocular and binocular) were measured using a glarometer on integer scales of 1-5, where the smaller the number the better the outcome.
Visit 4 (4-6 months)
Binocular Halo and Starburst
Time Frame: Visit 3 (2-3 months)
Halo and starburst (both monocular and binocular) were measured using a glarometer on integer scales of 1-5, where the smaller the number the better the outcome.
Visit 3 (2-3 months)
Binocular Halo and Starburst
Time Frame: Visit 4 (4-6 months)
Halo and starburst (both monocular and binocular) were measured using a glarometer on integer scales of 1-5, where the smaller the number the better the outcome.
Visit 4 (4-6 months)
Manifest Refraction
Time Frame: Visit 3 (2-3 Months)
Manifest refraction spherical equivalent (MRSE) was calculated as the value of the sphere plus one-half of the value of the cylinder.
Visit 3 (2-3 Months)
Manifest Refraction
Time Frame: Visit 4 (4-6 Months)
Manifest refraction spherical equivalent (MRSE) was calculated as the value of the sphere plus one-half of the value of the cylinder.
Visit 4 (4-6 Months)
Uncorrected Distance Visual Acuity
Time Frame: Visit 3 (2-3 months) Visit 4 (4-6 months)
High Contrast Uncorrected Distance (UCDVA) measured at 32 inches, Intermediate (UCIVA) at 32 inches, and Near Visual Acuity (UCNVA) at 16 inches
Visit 3 (2-3 months) Visit 4 (4-6 months)
Best-corrected Distance Visual Acuity
Time Frame: Visit 3 (2-3 months) Visit 4 (4-6 months)
High Contrast Distance-Corrected Distance,(BCDVA), Intermediate (DCIVA), and Near Visual Acuity (DCNVA)
Visit 3 (2-3 months) Visit 4 (4-6 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Omid Khodai, OD, RAC, Bausch & Lomb Incorporated

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2010

Primary Completion (ACTUAL)

June 1, 2012

Study Completion (ACTUAL)

September 1, 2012

Study Registration Dates

First Submitted

May 11, 2010

First Submitted That Met QC Criteria

May 12, 2010

First Posted (ESTIMATE)

May 13, 2010

Study Record Updates

Last Update Posted (ESTIMATE)

March 28, 2014

Last Update Submitted That Met QC Criteria

February 12, 2014

Last Verified

February 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 651 (CHM)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract

Clinical Trials on Crystalens AO

3
Subscribe